Inflammatory and bone biomarkers/composites as a predictive tool for clinical characteristics of rheumatoid arthritis patients
Open Access
- 23 February 2022
- journal article
- research article
- Published by University of Szeged in Acta Biologica Szegediensis
- Vol. 2 (65) , 271-283
Abstract
Rheumatoid arthritis (RA) is related to alterations in different inflammatory and connective tissue biomarkers. The diagnostic values and the factors affecting these biomarkers are conflicting. In the present study, a bone-related composite (B-composite), made from the z-score of stromelysin-1 (MMP3), colony-stimulating factor 2 (CSF2), and osteopontin (OPN), and I-composite, reflecting immune activation, made from the z-score of tumor necrosis factor-α (TNFα), interferon-γ (INFγ), and vascular endothelial growth factor-A (VEGF) were examined in RA patients. The biomarkers were measured by ELISA technique in 102 RA patients and 58 age-matched healthy control subjects. Serum MMP3, TNFα, IFNγ, and CSF2 showed significant elevation in RA patients. Multivariate general linear model (GLM) analysis revealed a significant high effect of diagnosis on biomarkers' level (partial η2 = 0.415). Duration of disease is significantly associated with VEGF, OPN, and B-composite and negatively correlated with TNFα. B-composite is significantly associated with CRP. A significant fraction of the DAS28 score variance can be explained by the regression on zlnINFγ. The variance in the CRP was explained by zlnOPN and B-composite. More than half of anti-citrullinated protein antibodies (ACPA) variation can be explained by the regression on serum MMP3 and I-composite. The top 3 sensitive predictors for RA disease are INFγ, MMP3, and TNFα. B-composite is associated with the duration of disease and CRP. At the same time, I-composite is negatively associated with the ACPA level. The biomarker composites have potential use as RA disease characteristic biomarkers.Keywords
This publication has 77 references indexed in Scilit:
- Correlation between circulating VEGF levels and disease activity in rheumatoid arthritis: a meta-analysisZeitschrift für Rheumatologie, 2016
- Association Between Inflammatory Biomarkers and Bone Mineral Density in a Community‐Based Cohort of Men and WomenArthritis Care & Research, 2013
- Development of the anti–citrullinated protein antibody repertoire prior to the onset of rheumatoid arthritisArthritis & Rheumatism, 2011
- Absence of changes in the number of synovial sublining macrophages after ineffective treatment for rheumatoid arthritis: Implications for use of synovial sublining macrophages as a biomarkerArthritis & Rheumatism, 2007
- Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: A prospective cohort studyArthritis & Rheumatism, 2004
- Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritisArthritis & Rheumatism, 2003
- Production of Cytokines and Metalloproteinases in Rheumatoid Synovitis Is T Cell DependentClinical Immunology, 1999
- A randomized, double‐blind study comparing twenty‐four‐week treatment with recombinant interferon‐γ versus placebo in the treatment of rheumatoid arthritisArthritis & Rheumatism, 1997
- Measurement of colony-stimulating factors in synovial fluid: potential clinical valueRheumatology International, 1995
- Differential expression of gelatinase B (MMP-9) and stromelysin-1 (MMP-3) by rheumatoid synovial cells in vitro and in vivoRheumatology International, 1993